Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

SEQ koala population carries immunity to retrovirus

Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...

Content from other channels on our network

Western Sydney Local Health District prosecution withdrawn

Bankstown-Lidcombe and Liverpool Hospitals trial body cameras

Brain and kidney injury treatment after cardiac surgery

Thousands of NSW public hospital doctors to strike next week

Gentle care practices to help reduce pressure injury risk factors

EPOC Enviro secures patent for PFAS remediation technology

NSW passes legislation to mandate battery recycling

Climate Council rates political parties on climate

Boral secures grant for cement kiln carbon reduction

Canadian Solar and Flow Power to install anti-hail solar

Egg producer improves efficiency with flexible marking system

Visy announces new insulation to reduce the use of polystyrene

New liquid catalyst to transform chemical manufacturing

Climate Smart Engineering Conference 2025: program announced

Aussie manufacturing conditions improve at fastest pace since 2022